Imipramine, desipramine and nortriptyline should be monitored using plasma levels, as their plasma levels have been demonstrated to relate accurately to clinical outcome (Roose and Glassman, 1994). Moreover, blood levels should be measured for nortriptyline because a significant proportion of general population are slow metabolizers of the drug (Souery et al., 2001).
Ref: -
Roose, S.P. & Glassman, A.H. (1994) Treatment with tricyclic antidepressants: defining the refractory patient. In: Refractory depression: Current strategies and future directions. (Eds.) Nolen, W.A., Zohar, J., Roose, S.P. & Amsterdam, J.D. Chichester, UK: John Wiley.
Souery, D., Lipp, O., Massat, I. & Mendlewicz, J. (2001). The characterization and definition of treatment-resistant mood disorders. In: Treatment-resistant mood disorders, (Eds.) Amsterdam, J.D., Hornig, M. & Nierenberg, A.A. pp 3 – 29, Cambridge: Cambridge University Press.
No Pingbacks for this post yet...
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
| << < | > >> | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | ||||
This blog on Clinical Psychopharmacology is maintained by Dr. Shahul Ameen, M.D., Psychiatrist, St. John's Hospital, Kattappana, Idukki, Kerala, India.
Psychopharmacology Tips is a part of PsyPlexus, a portal for mental health professionals.
This blog is only for educational purpose of psychiatrists and other physicians. The information published in this blog is not intended for use as a substitute for consultation to a licensed health professional. Patients and consumers who visit Psychopharmacology Tips should carefully review the information gathered from the site with a professional healthcare provider.